The business had 14 members of staff
A UK-based research company has collapsed into liquidation after a buyer could not be found to save it.
TC BioPharm has made all 14 members of its staff redundant after the news.
Founded in 2013, it focused on cancer research and was listed on the US Nasdaq exchange until last year.
READ MORE: Martin Lewis shares NHS ‘season ticket’ advice to avoid overcharging
Michael Magnay and Rob Croxen, of Alvarez & Marsal, were appointed administrators of TC BioPharm last year, The Herald reports.
They have now been made joint liquidators.
Documents read: “The company carried out research into blood cancer treatments from its Motherwell…